An international research team co-led by the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC-CSIC-University of Cantabria) and CIC bioGUNE, member of BRTA, has identified a novel molecular mechanism that helps limit the progression of several types of cancer.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗